<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To compare the clinical parameters, C-<z:chebi fb="7" ids="16670">peptide</z:chebi> levels, pattern of islet cell-specific autoantibodies, and prevalence of predisposing genotypes in subjects with latent autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> in adults (LADA) and those with <z:hpo ids='HP_0003581'>adult-onset</z:hpo> type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> with <z:hpo ids='HP_0003678'>rapid progression</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: We evaluated the clinical parameters, C-<z:chebi fb="7" ids="16670">peptide</z:chebi> levels, and islet cell-specific autoantibodies in 54 LADA, 57 <z:hpo ids='HP_0003581'>adult-onset</z:hpo> type 1 diabetic, and 190 type 2 diabetic patients </plain></SENT>
<SENT sid="2" pm="."><plain>Islet cell autoantibodies were also compared between subgroups of newly diagnosed patients with LADA and those with newly diagnosed <z:hpo ids='HP_0003581'>adult-onset</z:hpo> and <z:hpo ids='HP_0011463'>childhood-onset</z:hpo> type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>The genetic study was performed in subjects with LADA and those with <z:hpo ids='HP_0003581'>adult-onset</z:hpo> type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> in comparison with a control population </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: There were no differences in the clinical parameters between LADA and <z:hpo ids='HP_0003581'>adult-onset</z:hpo> type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Patients with LADA had lower BMI (P &lt; 0.0001), waist-to-hip ratio (0.0029), total cholesterol (P = 0.001), and <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (P = 0.001); higher <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> levels (P &lt; 0.0001); and lower prevalence of <z:hpo ids='HP_0000822'>hypertension</z:hpo> (P = 0.0028) compared with patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>C-<z:chebi fb="7" ids="16670">peptide</z:chebi> levels were similar at <z:hpo ids='HP_0003674'>onset</z:hpo> (P = 0.403) but decreased less rapidly in LADA than in <z:hpo ids='HP_0003581'>adult-onset</z:hpo> type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> (P = 0.0253) </plain></SENT>
<SENT sid="7" pm="."><plain>Single-autoantibody positivity was more often seen in LADA than in type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> (P = 0.0001) </plain></SENT>
<SENT sid="8" pm="."><plain>The prevalence of predisposing HLA-DQB1*0302, -DR4, -DR3, and -DR3/DR4 genotypes and the DR4-DQB1*0302 haplotype were increased in both LADA and <z:hpo ids='HP_0003581'>adult-onset</z:hpo> type 1 diabetic subjects compared with the control population </plain></SENT>
<SENT sid="9" pm="."><plain>There were no differences in the frequencies of these risk alleles and haplotypes between the two patient groups </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Subjects with LADA had clinical characteristics similar to those with <z:hpo ids='HP_0003581'>adult-onset</z:hpo> type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> with <z:hpo ids='HP_0003678'>rapid progression</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>C-<z:chebi fb="7" ids="16670">peptide</z:chebi> levels did not differ at <z:hpo ids='HP_0003674'>onset</z:hpo> but decreased less rapidly in LADA </plain></SENT>
<SENT sid="12" pm="."><plain>Patients with LADA rather had single islet cell-specific autoantibody positivity </plain></SENT>
<SENT sid="13" pm="."><plain>The prevalence of HLA-DQB1*0302, -DR4, -DR3, and -DR3/DR4 risk alleles and the DR4-DQB1*0302 high-risk haplotype did not differ in the two forms of autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>